What documentation is available before you order
Pain management and physical medicine practices considering a new biologics vendor typically want to see the testing record behind a product before it reaches a purchase order. Precision Biologics makes the certificate of analysis, donor eligibility summary, and lot release record available to verified accounts for the specific lot under review.
For exosome products, supplier-reported characterization data, such as particle concentration and marker identification, is included in that documentation set so a practice's clinical and compliance staff can evaluate it directly.
Topeka
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
30- Pain Medicine
- 8
- Physical Medicine & Rehabilitation
- 22
Confirming where a product fits your regulatory framework
Whether a specific intended use fits a practice's existing regulatory framework is a determination for the practice and its own legal counsel, not something Precision Biologics advises on.
We recommend raising any open question with the Kansas medical board directly. Verified accounts can also arrange a physician-level conversation about product documentation through their account representative, separate from any clinical advice.
Account setup and NPI verification
Setting up an account starts with an NPI number, checked against the NPPES registry before activation. This keeps purchasing limited to licensed professionals and creates a clear record for later compliance review.
Practices with multiple locations or multiple treating physicians should decide in advance which NPI the account will be tied to, which speeds up verification.
Cold-chain shipping
Cryopreserved product ships overnight on dry ice in a validated container and is stored at -80 degrees C until shipment; lyophilized product ships at ambient temperature and is reconstituted per the insert included with the lot.
A Topeka practice should designate who receives shipments and how lot numbers get logged against the documentation for each order.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Is pricing listed for pain management accounts in Topeka?+
No. Pricing is available to verified accounts after NPI verification is complete.
Can our practice request exosome characterization data before ordering?+
Yes. Supplier-reported particle concentration and marker testing data is available to verified accounts for review.
Who handles questions about whether a product fits our clinical framework?+
That is a determination for your medical director and legal counsel. We recommend confirming any specifics with the Kansas medical board.